CLEC5A and cancer: By univariate Cox regression analysis of 32 cancer types, we found that high CLEC5A expression indicated poor OS and DFS in patients with THCA, LGG, PAAD, GBM, CESC, LICH, KIRC, and OV but predicted better OS and DFS in patients with SKCM, UCS, and KIRP (Figures 1E, F).